SCHEMBL7426358

SCHEMBL7426358

COC(=O)Cc1cccc(NC(=O)c2cccc3ccccc23)c1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.58
MEN1 O00255 4/20 0.58
NR1H4 Q96RI1 2/20 0.56
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54
SIRT2 Q8IXJ6 1/20 0.53
SIRT3 Q9NTG7 1/20 0.53
DEGS1 O15121 1/20 0.52
KDM4E B2RXH2 1/20 0.52
SENP1 Q9P0U3 1/20 0.51
PPARD Q03181 2/20 0.50
PARP1 P09874 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
BACE1 P56817 1/20 0.49
PPARG P37231 1/20 0.49
PPARA Q07869 1/20 0.49
KCNK3 O14649 1/20 0.49
KCNK9 Q9NPC2 1/20 0.49
ACKR3 P25106 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7433413 0.87 NR1H4 (0.74) KMT2AMEN1NR1H4NPC1RAB9A
SCHEMBL7427460 0.86 NR1H4 (0.76) KMT2AMEN1NR1H4NPC1RAB9A
SCHEMBL27795055 0.82 PLG (0.60) KMT2AMEN1NR1H4NPC1RAB9A
SCHEMBL3060113 0.81 ALDH1A1 (0.54) KMT2AMEN1NPC1RAB9AKDM4E
SCHEMBL7740939 0.80 KMT2A (0.63) KMT2AMEN1NR1H4NPC1RAB9A
SCHEMBL7435795 0.80 NR1H4 (0.64) KMT2AMEN1NR1H4NPC1RAB9A
SCHEMBL27852778 0.80 MEN1 (0.57) KMT2AMEN1NR1H4NPC1RAB9A
SCHEMBL12800038 0.79 P2RX1 (0.58) KMT2AMEN1NPC1RAB9AKDM4E
SCHEMBL20847994 0.77 NPC1 (0.73) KMT2AMEN1NPC1RAB9ADEGS1
SCHEMBL7425090 0.77 SLC16A3 (0.59) KMT2AMEN1NR1H4NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000061631-A1 MODIFIED PENTAPEPTIDE ANTAGONISTS OF THE ATRIAL NATRIURETIC PEPTIDE CLEARANCE RECEPTOR ASTRAZENECA AB (SE) 2000-10-19 WO disclosed